1. Home
  2. PLBC vs ZNTL Comparison

PLBC vs ZNTL Comparison

Compare PLBC & ZNTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PLBC
  • ZNTL
  • Stock Information
  • Founded
  • PLBC 1980
  • ZNTL 2014
  • Country
  • PLBC United States
  • ZNTL United States
  • Employees
  • PLBC N/A
  • ZNTL N/A
  • Industry
  • PLBC Finance Companies
  • ZNTL Biotechnology: Pharmaceutical Preparations
  • Sector
  • PLBC Finance
  • ZNTL Health Care
  • Exchange
  • PLBC Nasdaq
  • ZNTL Nasdaq
  • Market Cap
  • PLBC 253.9M
  • ZNTL 227.0M
  • IPO Year
  • PLBC 2005
  • ZNTL 2020
  • Fundamental
  • Price
  • PLBC $46.73
  • ZNTL $2.31
  • Analyst Decision
  • PLBC Buy
  • ZNTL Buy
  • Analyst Count
  • PLBC 2
  • ZNTL 8
  • Target Price
  • PLBC $54.50
  • ZNTL $10.50
  • AVG Volume (30 Days)
  • PLBC 11.8K
  • ZNTL 1.6M
  • Earning Date
  • PLBC 01-15-2025
  • ZNTL 02-25-2025
  • Dividend Yield
  • PLBC 2.25%
  • ZNTL N/A
  • EPS Growth
  • PLBC N/A
  • ZNTL N/A
  • EPS
  • PLBC 4.80
  • ZNTL N/A
  • Revenue
  • PLBC $81,275,000.00
  • ZNTL $40,560,000.00
  • Revenue This Year
  • PLBC N/A
  • ZNTL N/A
  • Revenue Next Year
  • PLBC $15.50
  • ZNTL N/A
  • P/E Ratio
  • PLBC $9.73
  • ZNTL N/A
  • Revenue Growth
  • PLBC 4.55
  • ZNTL N/A
  • 52 Week Low
  • PLBC $32.50
  • ZNTL $2.16
  • 52 Week High
  • PLBC $51.33
  • ZNTL $18.07
  • Technical
  • Relative Strength Index (RSI)
  • PLBC 52.15
  • ZNTL 34.68
  • Support Level
  • PLBC $45.14
  • ZNTL $2.16
  • Resistance Level
  • PLBC $47.08
  • ZNTL $2.93
  • Average True Range (ATR)
  • PLBC 1.46
  • ZNTL 0.27
  • MACD
  • PLBC 0.15
  • ZNTL -0.06
  • Stochastic Oscillator
  • PLBC 71.49
  • ZNTL 11.97

About PLBC Plumas Bancorp

Plumas Bancorp is a bank holding company that provides various banking products and services in Northeastern California and Northwestern Nevada. It provides various deposit products such as checking, interest-bearing checking, business sweep, public funds sweep, savings, time deposit, and retirement accounts. The bank's loan portfolio consists of commercial real estate loans; commercial and industrial loans; consumer loans; agricultural loans; residential real estate loans, and construction and land development loans. The bank generates revenue from loans and investment securities in its portfolio and, to a lesser extent, service fees.

About ZNTL Zentalis Pharmaceuticals Inc.

Zentalis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering and developing small molecule therapeutics targeting fundamental biological pathways of cancers. It uses a drug discovery engine, which it refers to as an Integrated Discovery Engine, to identify targets and develop small molecule new chemical entities, or NCEs, with properties that it believes could result in potentially differentiated product profiles. It has two lead product candidates under pipeline: ZN-c5, for the treatment of advanced estrogen receptor-positive, human epidermal growth factor receptor 2-negative, or ER+/HER2-, advanced or metastatic breast cancer; and ZN-c3, for the treatment of advanced solid tumors as monotherapy and ovarian cancer.

Share on Social Networks: